Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5540262

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of PKCalpha (unknown origin)
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Protein kinase C alpha type (CHEMBL299)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma.
Visser M, Papillon JPN, Luzzio M, LaMarche MJ, Fan J, Michael W, Wang D, Zhang A, Straub C, Mathieu S, Kato M, Palermo M, Chen C, Ramsey T, Joud C, Barrett R, Vattay A, Guo R, Bric A, Chung F, Liang G, Romanowski MJ, Lam J, Thohan S, Atassi F, Wylie A, Cooke VG.
J Med Chem (2024) 67 : 1447 -1459
PubMed 38198520 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 2 7.90 8.19

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL565612 SOTRASTAURIN 2.0 1 8.19
CHEMBL3982723 DAROVASERTIB 2.0 1 7.60

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL565612 SOTRASTAURIN IC50 = 6.4 nM 8.19
CHEMBL3982723 DAROVASERTIB IC50 = 25.2 nM 7.60